Highly efficient hydrazination of conjugated nitroalkenes via imidazole or DMAP mediated Morita-Baylis-Hillman reaction

Novel alpha-hydrazino-alpha,beta-unsaturated nitroalkenes, which exhibit dynamic phenomenon on the NMR time scale, were synthesized in excellent yields via imidazole or DMAP mediated Morita-Baylis-Hillman (MBH) type reaction of nitroalkenes with azodicarboxylates.     

Syntheses and characterization of a new class of vanadia precursors of oxime-modified oxovanadium(V) isopropoxide,crystal and molecular structure of [VO{ONC10H16}3]

Modification of [VO(OPrⁱ)₃] with oximes in different molar ratios, yielded new class of vanadia precursors, [VO{OPrⁱ}_3?n{L}_n] {where, n = 1–3 and LH = C₉H₁₆C=NOH (1–3) and (CH₃)₂C=NOH (4–6)}.All the products are yellow in colour. (1) and (2) are liquid/viscous liquid, while others are solids. Molecular weight measurements of all these derivatives and the ESI-mass spectral studies of (1), (2), (3) and (5) indicate their monomeric nature. ¹H and ¹³C{¹H} NMR spectra suggest that the oximato moieties are monodentate in solution which was further confirmed by the ⁵¹V NMR signals, appeared in the region expected for tetra-coordinated oxo-vanadium atoms. On ageing, a disproportionation reaction occurs in (1) and some crystals appeared. Single crystal X-ray diffraction analyses of the crystals obtained from (1) as well as from (3) were found to be the same and indicate the presence of side-on {dihapto η ²-(N, O)} binding modes of the oximato ligands, leading to the formation of seven coordination environment around the vanadium atom. Thermogravimetric curve of (1) exhibits multi-step decomposition with the formation of V₂O₅ as the final product at ~850 °C. Sol–gel transformation of (3) yielded (a) VO₂ sintered at 300 °C and (b) V₂O₅ at 600 °C. Similarly, sol–gel transformations of (1) and (2) yielded V₂O₅ (c) and (d) at 600 °C, respectively. Formation of monoclinic phase in (a) and orthorhombic phase in (b), (c) and (d) were confirmed by powder XRD patterns.     

Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria

Ginseng is a vastly used herbal supplement in Southeast Asian countries. Red ginseng extract enriched with Rg3 (Rg3-RGE) is a formula that has been extensively studied owing to its various biological properties. Persicaria tinctoria (PT), belonging to the Polygonaceae family, has also been reported for its anti-inflammatory properties. Ulcerative colitis (UC) is inflammation of the large intestine, particularly in the colon. This disease is increasingly common and has high probability of relapse. We investigated, separately and in combination, the effects of Rg3-RGE and PT using murine exemplary of UC induced by DSS (Dextran Sulfate Sodium). For in vitro and in vivo experiments, nitric oxide assay, qRT-Polymerase Chain Reaction (PCR), Western blot, ulcerative colitis introduced by DSS, Enzyme Linked Immunosorbent Assay (ELISA), and flow cytometry analysis were performed. The results obtained demonstrate that treatment with Rg3-RGE + PT showed synergism to suppress inflammation (in vitro) in RAW 264.7 cells via mitogen-activated protein kinase and nuclear factor κB pathways. Moreover, in C57BL/6 mice, this mixture exhibits strong anti-inflammatory effects in restoring colon length, histopathological damage, pro-inflammatory mediators, and cytokines amount, and decreasing levels of NLRP3 inflammasome (in vivo). Our results recommend that this mixture can be used for the prevention of UC as a prophylactic/therapeutic supplement.     

Redox-rich spin-spin-coupled semiquinoneruthenium dimers with intense near-IR absorption

Using the [RuCl(μ-tppz)ClRu](2+) [tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine] platform for bridging two o-quinone/catecholate two-step redox systems (unsubstituted, Q(n), or 3,5- di-tert-butyl-substituted, DTBQ(n)), we have obtained the stable complexes [(Q(?-))Ru(II)Cl(μ-tppz)ClRu(II)(Q(?-))] (1) and the structurally characterized [(DTBQ(?-))Ru(II)Cl(μ-tppz)ClRu(II)(DTBQ(?-))] (2). The compounds exhibit mostly quinone-ligand-based redox activity within a narrow potential range, high-intensity near-IR absorptions (λ(max) ≈ 920 nm; ε > 50,000 M(-1) cm(-1)), and variable intra- and intermolecular spin-spin interactions. Density functional theory calculations, electron paramagnetic resonance (EPR), and spectroelectrochemical results (UV-vis-near-IR region) for three one-electron-reduction and two one-electron-oxidation processes were used to probe the electronic structures of the systems in the various accessible valence states. EPR spectroscopy of the singly charged doublet species showed semiquinone-type response for 1(+), 2(+), and 2(-), while 1 exhibits more metal based spin, a consequence of the easier reduction of Q as compared to DTBQ. Comparison with the analogous redox series involving a more basic N-phenyliminoquinone ligand reveals significant differences related to the shifted redox potentials, different space requirements, and different interactions between the metals and the quinone-type ligands. As a result, the tppz bridge is reduced here only after full reduction of the terminal quinone ligands to their catecholate states.     

Determination of albendazole and its metabolites in the muscle tissue of hybrid striped and largemouth bass using liquid chromatography with fluorescence detection

A liquid chromatographic method was developed for the determination of albendazole and its metabolites albendazole sulfoxide, albendazole sulfone, and albendazole-2-aminosulfone from largemouth and hybrid striped bass muscle tissue with adhering skin. The muscle tissue samples were made alkaline with potassium carbonate and extracted with ethyl acetate. The extracts were further subjected to cleanup by using a series of liquid-liquid extractions. After solvent evaporation, the residue was reconstituted in mobile phase and chromatographed. The chromatography was carried out on a reversed-phase Luna C18 column, using acetonitrile-methanol buffer as the mobile phase. The analytes were detected by fluorescence with excitation and emission wavelengths of 290 and 330 nm, respectively. The average recoveries from the fortified muscle tissue of the 2 fish species for albendazole (25-100 ppb), albendazole sulfoxide (8.75-52.5 ppb), albendazole sulfone (1-10 ppb), and albendazole-2-aminosulfone (10-100 ppb) were 89, 82, 99, and 74%, respectively. The coefficient of variation for each compound was <20% in all cases. The procedure was applied to the determination of albendazole and its 3 metabolites in the muscle tissue of the 2 fish species after orally dosing them with albendazole.     

Phosphonobetaine/sulfur dioxide copolymer by Butler’s cyclopolymerization process

The zwitterionic monomer, ethyl 3-(N,N-diallylammonio)propanephosphonate and sulfur dioxide were cyclocopolymerized in DMSO using azobisisobutyronitrile or ammonium persulfate as initiators to afford a pH-responsive polyphosphonobetaine/SO₂ (PPB/SO₂) copolymer. The polymers, on treatment with HCl and NaOH, gave the aqueous solutions of the corresponding cationic polyphosphononic acid (CPP) and anionic polyphosphonate (APP). The solution properties of the PPB having two pH-responsive functionalities were investigated in detail by potentiometric and viscometric techniques. Basicity constants of the amine and phosphonate groups in APP were found to be “apparent” and as such follow the modified Henderson–Hasselbalch equation. The incorporation of SO₂ moiety has resulted in the decrease of basicity constant of the nitrogens in the copolymer by staggering ?2 units of log K in compare to that of the corresponding homopolymer. The basicity difference is expected to have an effect on the chelating properties of the polymers. In contrast to many polycarbo- and -sulfobetaines, the PPB was all found to be soluble in salt-free water as well as in salt (including Ca²⁺ and Li⁺)-added solutions. The PPB demonstrated ‘antipolyelectrolyte’ viscosity behavior and found to have higher viscosity values in LiCl than in NaCl or NaI.     

Simultaneous detection and quantification of parecoxib and valdecoxib in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology

Parecoxib is the injectable prodrug of valdecoxib, a cicloxygenase-2 selective drug, currently used in human medicine. Recent studies have suggested both its excellent clinical effectiveness and wide safety profile. The aim of the present study was to develop and validate a new high-performance liquid chromatography (HPLC) with spectrofluorimetric detection method to quantify parecoxib and valdecoxib in canine plasma. Several parameters both in the extraction and the detection method were evaluated. The applicability of the method was determined by administering parecoxib to one dog: the protocol provided the expected pharmacokinetic results. The final mobile phase was acetonitrile: AcONH₄ (10 mM; pH 5.0) 55:45, v/v, with a flow rate of 0.4 mL min⁻¹, and excitation and emission wavelengths of 265 and 375 nm, respectively. The analytical column was a reverse-phase C18 ODS2 3-μm particle size. Protein precipitation in acidic medium followed by two successive liquid–liquid steps was carried out. The best extraction solvent was cyclohexane:Et₂O (3:2, v/v) that gave recoveries ranging from 81.1% to 89.1% and from 94.8% to 103.6% for parecoxib and valdecoxib, respectively. The limits of quantification were 25 and 10 ng mL⁻¹ for parecoxib and valdecoxib, respectively. The chromatographic runs were specific with no interfering peaks at the retention times of the analytes, as confirmed by HPLC–mass spectrometry experiments. The other validation parameters were in agreement with the European Medicines Evaluation Agency and International Conference on Harmonisation guidelines. In conclusion, this method (extraction, separation and applied techniques) is simple and effective. This is the first time that use of a HPLC with spectrofluorimetric detection technique to simultaneously detect parecoxib and valdecoxib in plasma has been reported. This technique may have applications for pharmacokinetic studies.     

Aluminium nitride catalyzed solvent-free synthesis of some novel biologically active α-aminophosphonates

A green and atom-efficient one-pot protocol for the synthesis of some novel α-aminophosphonates using micron-particulate AlN/Al as a new reusable heterogeneous catalyst by the Kabachnik–Fields reaction under solvent-free conditions has been developed. The synthesized α-aminophosphonates were screened for several biological activities. They all were investigated to exhibit moderate to promising antioxidant, anti-inflammatory and cytotoxic properties.